Larsson LG; Rényi L; Ross SB; Svensson B; Angeby-Möller K (fevereiro de 1990). «Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT». Neuropharmacology. 29 (2): 85–91. PMID1691832. doi:10.1016/0028-3908(90)90047-U
Sprouse J; Reynolds L; Li X; Braselton J; Schmidt A (janeiro de 2004). «8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production». Neuropharmacology. 46 (1): 52–62. PMID14654097. doi:10.1016/j.neuropharm.2003.08.007
Wölfel R; Graefe KH (fevereiro de 1992). «Evidence for various tryptamines and related compounds acting as substrates of the platelet 5-hydroxytryptamine transporter». Naunyn-Schmiedeberg's Archives of Pharmacology. 345 (2): 129–36. PMID1570019. doi:10.1007/BF00165727
Schreiber R; De Vry J (novembro de 1993). «Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat». European Journal of Pharmacology. 249 (3): 341–51. PMID7904566. doi:10.1016/0014-2999(93)90531-L
de Boer SF; Koolhaas JM (dezembro de 2005). «5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis». European Journal of Pharmacology. 526 (1–3): 125–39. PMID16310183. doi:10.1016/j.ejphar.2005.09.065
Dourish CT; Hutson PH; Curzon G (outubro de 1985). «Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT)». Brain Research Bulletin. 15 (4): 377–84. PMID2933126. doi:10.1016/0361-9230(85)90005-X
Lucot JB (fevereiro de 1994). «Antiemetic effects of flesinoxan in cats: comparisons with 8-hydroxy-2-(di-n-propylamino)tetralin». European Journal of Pharmacology. 253 (1–2): 53–60. PMID8013549. doi:10.1016/0014-2999(94)90756-0
Fozard JR; Mir AK; Middlemiss DN (março de 1987). «Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis». Journal of Cardiovascular Pharmacology. 9 (3): 328–47. PMID2437400. doi:10.1097/00005344-198703000-00010
Meyer LC; Fuller A; Mitchell D (fevereiro de 2006). «Zacopride and 8-OH-DPAT reverse opioid-induced respiratory depression and hypoxia but not catatonic immobilization in goats». American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 290 (2): R405–13. PMID16166206. doi:10.1152/ajpregu.00440.2005
Guenther U; Manzke T; Wrigge H; Dutschmann M; Zinserling J; Putensen C; Hoeft A (abril de 2009). «The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo». Anesthesia and Analgesia. 108 (4): 1169–76. PMID19299781. doi:10.1213/ane.0b013e318198f828
Larsson LG; Rényi L; Ross SB; Svensson B; Angeby-Möller K (fevereiro de 1990). «Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT». Neuropharmacology. 29 (2): 85–91. PMID1691832. doi:10.1016/0028-3908(90)90047-U
Sprouse J; Reynolds L; Li X; Braselton J; Schmidt A (janeiro de 2004). «8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production». Neuropharmacology. 46 (1): 52–62. PMID14654097. doi:10.1016/j.neuropharm.2003.08.007
Wölfel R; Graefe KH (fevereiro de 1992). «Evidence for various tryptamines and related compounds acting as substrates of the platelet 5-hydroxytryptamine transporter». Naunyn-Schmiedeberg's Archives of Pharmacology. 345 (2): 129–36. PMID1570019. doi:10.1007/BF00165727
Schreiber R; De Vry J (novembro de 1993). «Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat». European Journal of Pharmacology. 249 (3): 341–51. PMID7904566. doi:10.1016/0014-2999(93)90531-L
de Boer SF; Koolhaas JM (dezembro de 2005). «5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis». European Journal of Pharmacology. 526 (1–3): 125–39. PMID16310183. doi:10.1016/j.ejphar.2005.09.065
Dourish CT; Hutson PH; Curzon G (outubro de 1985). «Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT)». Brain Research Bulletin. 15 (4): 377–84. PMID2933126. doi:10.1016/0361-9230(85)90005-X
Lucot JB (fevereiro de 1994). «Antiemetic effects of flesinoxan in cats: comparisons with 8-hydroxy-2-(di-n-propylamino)tetralin». European Journal of Pharmacology. 253 (1–2): 53–60. PMID8013549. doi:10.1016/0014-2999(94)90756-0
Fozard JR; Mir AK; Middlemiss DN (março de 1987). «Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis». Journal of Cardiovascular Pharmacology. 9 (3): 328–47. PMID2437400. doi:10.1097/00005344-198703000-00010
Sahibzada N; Ferreira M; Wasserman AM; Taveira-DaSilva AM; Gillis RA (fevereiro de 2000). «Reversal of morphine-induced apnea in the anesthetized rat by drugs that activate 5-hydroxytryptamine(1A) receptors». The Journal of Pharmacology and Experimental Therapeutics. 292 (2): 704–13. PMID10640309
Meyer LC; Fuller A; Mitchell D (fevereiro de 2006). «Zacopride and 8-OH-DPAT reverse opioid-induced respiratory depression and hypoxia but not catatonic immobilization in goats». American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 290 (2): R405–13. PMID16166206. doi:10.1152/ajpregu.00440.2005
Guenther U; Manzke T; Wrigge H; Dutschmann M; Zinserling J; Putensen C; Hoeft A (abril de 2009). «The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo». Anesthesia and Analgesia. 108 (4): 1169–76. PMID19299781. doi:10.1213/ane.0b013e318198f828